PREDIERI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 32.497
EU - Europa 29.066
AS - Asia 18.636
SA - Sud America 2.366
AF - Africa 491
OC - Oceania 182
Continente sconosciuto - Info sul continente non disponibili 21
Totale 83.259
Nazione #
US - Stati Uniti d'America 31.719
IT - Italia 12.994
SG - Singapore 6.320
GB - Regno Unito 4.963
CN - Cina 4.702
SE - Svezia 3.484
HK - Hong Kong 2.288
DE - Germania 1.776
BR - Brasile 1.706
VN - Vietnam 1.693
FI - Finlandia 1.239
FR - Francia 1.010
UA - Ucraina 800
RU - Federazione Russa 715
TR - Turchia 580
KR - Corea 577
IN - India 547
CA - Canada 395
NL - Olanda 390
BD - Bangladesh 372
ID - Indonesia 311
BG - Bulgaria 307
JP - Giappone 223
MX - Messico 205
AR - Argentina 204
ES - Italia 194
IE - Irlanda 192
CH - Svizzera 154
PL - Polonia 150
ZA - Sudafrica 146
AU - Australia 144
PK - Pakistan 144
IQ - Iraq 142
EC - Ecuador 114
IR - Iran 97
BE - Belgio 90
EG - Egitto 90
LT - Lituania 89
AT - Austria 82
MY - Malesia 80
DK - Danimarca 79
VE - Venezuela 77
BZ - Belize 75
CO - Colombia 71
AE - Emirati Arabi Uniti 70
CL - Cile 64
CZ - Repubblica Ceca 55
PH - Filippine 54
TH - Thailandia 53
PT - Portogallo 47
UZ - Uzbekistan 46
MA - Marocco 45
PE - Perù 45
RO - Romania 45
SA - Arabia Saudita 45
PY - Paraguay 41
TW - Taiwan 38
GR - Grecia 37
NZ - Nuova Zelanda 37
JO - Giordania 36
DZ - Algeria 35
NP - Nepal 35
TN - Tunisia 35
KE - Kenya 32
IL - Israele 30
ET - Etiopia 26
AZ - Azerbaigian 23
RS - Serbia 22
BO - Bolivia 21
HU - Ungheria 21
DO - Repubblica Dominicana 19
AL - Albania 18
NG - Nigeria 18
KZ - Kazakistan 17
CR - Costa Rica 16
NO - Norvegia 15
UG - Uganda 15
UY - Uruguay 15
EU - Europa 13
PA - Panama 13
SM - San Marino 13
KW - Kuwait 11
OM - Oman 11
CY - Cipro 10
EE - Estonia 10
JM - Giamaica 10
SI - Slovenia 10
LB - Libano 9
SK - Slovacchia (Repubblica Slovacca) 9
AM - Armenia 8
GE - Georgia 8
HN - Honduras 8
LV - Lettonia 8
MT - Malta 8
PS - Palestinian Territory 8
GT - Guatemala 7
HR - Croazia 7
LK - Sri Lanka 7
MK - Macedonia 7
NI - Nicaragua 7
Totale 83.103
Città #
Singapore 4.267
Southend 3.321
Santa Clara 3.227
Ashburn 3.008
Fairfield 2.255
Hong Kong 2.209
Stockholm 1.810
San Jose 1.640
Chandler 1.624
Woodbridge 1.600
Houston 1.568
Hefei 1.418
Jacksonville 1.365
Dearborn 1.130
Milan 989
Rome 946
Helsinki 939
Nyköping 888
Ann Arbor 859
London 850
Seattle 846
Beijing 826
Wilmington 814
Cambridge 687
New York 573
Seoul 539
Los Angeles 529
Ho Chi Minh City 522
The Dalles 517
Council Bluffs 441
Naples 389
Hanoi 384
Munich 377
Bologna 353
Princeton 325
Chicago 311
Lauterbourg 294
Sofia 287
Modena 275
San Diego 255
Eugene 254
Palermo 251
Buffalo 241
Turin 233
Jakarta 220
Shanghai 220
Redwood City 217
Moscow 214
Izmir 208
Frankfurt am Main 195
Orem 188
Bremen 187
Bari 178
Dallas 176
São Paulo 165
Dublin 151
Florence 150
Catania 141
Tokyo 133
Padova 121
Verona 113
Toronto 111
Boardman 110
Columbus 109
Parma 104
Fremont 98
Chennai 97
Des Moines 95
Salt Lake City 95
Johannesburg 94
Warsaw 94
Da Nang 84
Montreal 84
Phoenix 84
Las Vegas 83
Albuquerque 78
Guangzhou 78
Amsterdam 75
Tampa 75
Belize City 74
Genoa 74
Haiphong 71
Nuremberg 71
Falls Church 70
Brescia 69
Mexico City 63
Mumbai 62
Atlanta 61
Dong Ket 61
Nanjing 61
Rio de Janeiro 61
Denver 60
Paris 60
Pescara 60
Turku 59
Brooklyn 56
Poplar 55
Redondo Beach 55
Cairo 53
Cagliari 52
Totale 52.369
Nome #
CASO CLINICO: SINDROME DA MICRODELEZIONE 16p11.2 PROSSIMALE 4.679
"Balanced translocation" T(3;11)(P21;Q13) in a lipoma from a girl with suspected MEN 1 Syndrome. 1.997
Diabete tipo 2 e obesità pediatrica: rassegna a cura dei Gruppi di Studio Obesità Infantile e Diabete della Società Italiana di Endocrinologia e Diabetologia Pediatrica 1.168
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.159
I DISORDINI DELLO SVILUPPO SESSUALE E LE MALFORMAZIONI DELL’APPARATO GENITALE 921
Si può “Valere” di più: un progetto italiano studia i disturbi alimentari negli adolescenti con diabete tipo 1. Dati preliminari 801
Gestione del Covid-19 in età pediatrica: documento di consenso 774
Effetti degli interferenti endocrini su crescita e sviluppo puberale 681
Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes 642
BODY EMOTIONAL MAP: STRUMENTO INNOVATIVO ED UTILE PER MIGLIORARE L’ADATTAMENTO DEI GENITORI ALLA DIAGNOSI DI DIABETE DI TIPO 1 DEL LORO BAMBINO 630
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 525
Lactobacillus reuteri oral administration improves periodontal disease in children and adolescents with type 1 diabetes 482
COMPLICANZE MACROVASCOLARI E MORTALITÀ NEL DIABETE TIPO 1 461
Oral Administration of Lactobacillus Reuteri Improves Periodontal Disease in Children and Adolescents with Type 1 Diabetes 448
MALATTIA PARODONTALE IN BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1: EFFICACIA DELLA SOMMINISTRAZIONE ORALE DI LACTOBACILLUS REUTERI 416
Hypospadias: clinical approach, surgical technique and outcome. Twenty years’ experience of a single centre 412
High basal serum allopregnanolone levels in overweight girls 410
IPERTENSIONE IN BAMBINI ED ADOLESCENTI AFFETTI DA DIABETE DI TIPO 1: ALTA PREVALENZA IDENTIFICATA TRAMITE L’UTILIZZO DEL MONITORAGGIO PRESSORIO AMBULATORIALE 410
The Effect of GnRH-Analogue Therapy on the Quality of Life of Patients with Central Precocious Puberty and their Families 384
Accuracy of SenseWear Pro2 armband to predict resting energy expenditure in childhood obesity. 384
Endothelial and heart dysfunction in children and adolescents with type 1 diabetes 380
Alti livelli di anticorpi antitransglutaminasi predicono la malattia celiaca in bambini e adolescenti italiani con diabete mellito tipo 1. 378
THE IMPACT OF SENSOR-AUGMENTED INSULIN PUMP (SAP) THERAPY ON QUALITY OF LIFE (QOL) IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (T1D) AND THEIR PARENTS 377
Effects of Exercise in Children and Adolescent with Type 1 Diabetes Mellitus 376
Diabetic ketoacidosis at the onset of disease during a national awareness campaign: a 2-year observational study in children aged 0-18 years 376
Childhood obesity and environmental pollutants: a dual relationship 374
IMPATTO DELLA TERAPIA CON ANALOGO DEL GNRH SULLA QUALITÀ DELLA VITA DEI PAZIENTI CON CPP E DELLE LORO FAMIGLIE 373
Long-term effects on growth, development, and metabolism of ALL treatment in childhood 373
CONSEGUENZE METABOLICHE A BREVE E LUNGO TERMINE IN PAZIENTI CON PUBERTÀ PRECOCE CENTRALE TRATTATI CON GNRHA IN ETÀ EVOLUTIVA: STUDIO LONGITUDINALE MONOCENTRICO 371
Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: a long term follow up study. 368
Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment. 366
Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study 365
Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting 362
DETERMINANTI DELLA HEALTH RELATED QUALITY OF LIFE (HRQOL) IN ADOLESCENTI OBESI ITALIANI 359
Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: The RIDI study 356
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: An Italian cohort study 353
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 352
Low serum allopregnanolone levels in girls with precocious pubarche 343
A 1-year long-term study on efficacy and safety of degludec in children and adolescents with type 1 diabetes 339
L’ipercolesterolemia familiare: terapia farmacologica 337
Dolore addominale acuto nelle adolescenti: le principali patologie di natura ginecologica 337
Brain-derived neurotrophic factor and epilepsy: a systematic review 331
Approaches to dyslipidemia treatment in children and adolescents 330
Effect of Weight Loss on Markers of Inflammation and Endothelial Function in Childhood Obesity 330
Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes 329
Growth hormone impaired secretion and antipituitary antibodies in patients with coeliac disease and poor catch-up growth after a long gluten-free diet period: a causal association? 320
VALUTAZIONE AUXO-ENDOCRINOLOGICA DEI PAZIENTI AFFETTI DA SICKLE CELL DISEASE (SCD): DATI PRELIMINARI 312
Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program 307
QUALITÀ DI VITA E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 E NEI LORO GENITORI PRIMA E DOPO IL LOCKDOWN PER COVID-19. 300
EFFICACIA E SICUREZZA DI DEGLUDEC NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 299
A Multicenter Retrospective Survey regarding Diabetic Ketoacidosis Management in Italian Children with Type 1 Diabetes 298
Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature 297
Efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes 296
COVID-19 and Type 1 Diabetes: Concerns and Challenges 296
Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. 295
High prevalence of hypertension in children and adolescents with type 1 diabetes identified through the 24 hours ambulatory blood pressure monitoring 292
Basi genetiche ed aspetti terapeutici delle ipercolesterolemie familiari 288
Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study 287
Obesity in pediatric age: The analysis of genomic rearrangements 287
Endocrine immune-related adverse effects of immune-checkpoint inhibitors 286
Plasma brain-derived neurotrophic factor concentrations in children and adolescents. 285
Weekend-Based Parent-Group Intervention to Reduce Stress in Parents of Children and Adolescents with Type 1 Diabetes: A Pilot Study 285
SHORT STATURE HOMEOBOX-CONTAINING GENE AND IDIOPATHIC SHORT STATURE 283
Relationship between body mass index and insulin measured during oral glucose tolerance testing in severely obese children and adolescents 283
Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients 283
Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: A review 282
Longitudinal study of the endothelial function in children and adolescents affected by type 1 diabetes mellitus 278
Health-Related Quality of Life and Metabolic Control in Immigrant and Italian Children and Adolescents with Type 1 Diabetes and in their Parents 275
Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic 274
Endocrine Disrupting Chemicals and Type 1 Diabetes 273
High levels of serum perfluorinated compounds in children with endocrine autoimmune disease. 270
Hypercholesterolemia in Childhood 270
Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry 269
Lipide profile, antioxidant factors and endothelial function in children and adolescent with type 1 diabetes mellitus 269
A new device for measuring resting energy expenditure in severely obese children and adolescents with and without non-alcoholic fatty liver disease. 269
Low-density lipoprotein oxidizability in children with chronic renal failure 268
Complex disease phenotype revealed by GH deficiency associated with a novel and unusual defect in the GH-1 gene. 266
Health-related quality of life and metabolic control in young patients with type 1 diabetes and in their parents before and after the COVID-19 lockdown 265
Tracheobronchial anomalies in chromosome 22q11.2 microdeletion 264
Thirty-year persistence of obesity after presentation to a pediatric obesity clinic. 264
Endocrine-disrupting chemicals and their effects during female puberty: A review of current evidence 264
Natural history of congenital hypothyroidism in the last two decades: what is changing? Experience of a single tertiary Italian paediatric centre 264
MicroRNAs change and target key regulatory genes involved in longitudinal growth in patients with idiopathic isolated growth hormone deficiency (IGHD) on growth hormone (GH) treatment 263
Evaluation and management of hyperlipidemia in children and adolescents. 262
Insulin pump failures in Italian children with Type 1 diabetes: retrospective 1-year cohort study 262
Efficacy and Safety of Degludec in Children and Adolescents with Type 1 Diabetes 261
Can inflammatory marker levels help in detecting early complications of childhood obesity? 260
Auxological data and glycemic control in children and adolescents with type 1 diabetes 2-years after the COVID-19 pandemic 258
Organization and regional distribution of centers for the management of children and adolescents with diabetes in Italy 258
Prevalence and risk factors for microalbuminuria in children and adolescents with type 1 diabetes: long-term experience of a single centre 257
High g-glutamyl-transferase fractions as new markers to identify non-alcoholic fatty liver disease in childhood obesity 257
Human amniotic epithelial cells (HAECs): a reliable source of insulin producing cells? 257
Efficacy of telemedicine in patients with type 1 diabetes over the second year by the COVID-19 pandemic spread 256
Endothelial function in adolescents with type 1 diabetes mellitus (TIDM) [Funzione endoteliale in adolescenti con diabete di tipo 1], 256
Adrenal Hypoplasia Seemingly First as a Primary Hypoaldosteronism 256
Allopregnanolone Levels Decrease after Gonadotropin Releasing Hormone Analogue Stimulation Test in Girls with Central Precocious Puberty. 256
Health-Related Quality of Life and Diabetes Control in Immigrant and Italian Children and Adolescents with Type 1 Diabetes and in their Parents 256
Rhabdomyoma of a rare type in a child: Case report and literature review 254
Confocal microscopy: Improving our understanding of nevogenesis 254
Markers of Inflammation and Endothelial Dysfunction in Young Survivors from Acute Lymphoblastic Leukemia 254
Totale 41.819
Categoria #
all - tutte 269.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 269.260


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021954 0 0 0 0 0 0 0 0 0 0 549 405
2021/20226.054 208 655 466 561 343 392 309 405 625 466 933 691
2022/20237.655 723 631 466 588 825 923 366 760 927 382 600 464
2023/20247.290 389 447 495 698 983 694 585 870 416 427 571 715
2024/202515.136 572 469 440 1.066 2.521 2.130 1.193 874 1.973 920 1.335 1.643
2025/202626.287 1.631 972 2.031 2.832 3.901 2.037 3.590 1.304 3.980 2.516 1.493 0
Totale 84.085